Intratect

Human Normal Immunoglobulin, the active ingredient in Intratect, is an immunoglobulin presented as a sterile solution for injection for intravenous use. It supplies pooled IgG antibodies that replace deficient immunity in patients with primary or secondary immunodeficiency conditions.

GNH USA supplies Intratect as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies, clinics and other healthcare facilities worldwide.

Intratect is used in immunoglobulin replacement therapy to address antibody deficiencies.

- Primary immunodeficiency diseases: Restores IgG levels to reduce infection frequency. - Secondary immunodeficiency conditions: Provides passive immunity when endogenous production is compromised. - Post‑bone marrow transplantation: Supports immune reconstitution during the early post‑transplant period.

Intratect may be associated with a range of adverse reactions following intravenous administration.

Common Side Effects: - Headache: mild to moderate discomfort occurring during or after infusion. - Fever or chills: transient rise in temperature or shivering. - Nausea: occasional upset stomach or feeling of queasiness. - Fatigue: temporary tiredness post‑infusion.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Thromboembolic events: blood clot formation in veins or arteries. - Acute renal failure: sudden loss of kidney function. - Aseptic meningitis: inflammation of the meninges without infection.

Before administering Intratect, several precautions should be observed to ensure patient safety. - Pre‑infusion screening: assess for IgA deficiency and prior allergic reactions. - Infusion rate: start slowly and increase gradually to reduce adverse reactions. - Hydration status: ensure adequate fluid intake to support renal function. - Concomitant medications: monitor use of anticoagulants or immunosuppressants. - Monitoring: observe vital signs and symptoms during and after infusion. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Intratect can interact with other medicines, influencing efficacy or safety.

Major Interactions (Avoid): - Live vaccines: may reduce vaccine efficacy; avoid concurrent administration. - High‑dose immunoglobulin products: increase risk of hyperviscosity; avoid simultaneous use.

Moderate Interactions (Monitor Closely): - Anticoagulants (e.g., warfarin): may potentiate anticoagulant effect; monitor INR. - Corticosteroids: may mask infusion reactions; observe patient closely. - Diuretics: can affect fluid balance; watch for volume overload.